Sublingual administration, which bypasses the gastrointestinal tract, appears to be equally effective as IM injections while being less invasive and more cost-efficientparticularly in patients with atrophic gastritis, post-gastrectomy status, or conditions that impair intrinsic factor-mediated absorption, where long-term intervention is often required
Consequently, the evidence that it may close and heal the various fistulas and improve anastomosis healing, may be a proof of the fulfilled wound healing concept
Gastrointestinal and Mucosal Protection Cytoprotective properties As a derivative of a gastric juice protein, BPC-157 has been studied extensively for its ability to protect and heal the gastrointestinal mucosa
Book Intro Call BPC-157 isn't FDA-approved for human use as of the writing of this article
There is currently no evidence showing that BPC-157 suppresses appetite